HK Stock MarketDetailed Quotes
01558 HEC CJ PHARM
- 12.500
- +0.420+3.48%
Market Closed Apr 25 16:09 CST
11.00BMarket Cap5.00P/E (TTM)
12.500High11.960Low2.24MVolume12.080Open12.080Pre Close27.65MTurnover0.34%Turnover Ratio5.00P/E (Static)879.97MShares13.04052wk High1.26P/B8.17BFloat Cap6.02052wk Low--Dividend TTM653.77MShs Float26.947Historical High--Dividend LFY4.47%Amplitude3.350Historical Low12.317Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
HEC CJ PHARM Key Stats
All
YOY
| (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 105.91%39.42M | ---- | -166.03%-667.18M | ---- | -55.47%1.01B | ---- | 105.84%2.27B | ---- | 47.33%1.1B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 40.60%-6.74M | ---- | 54.59%-11.35M | ---- | 30.66%-24.99M | ---- | -146.82%-36.04M | ---- | 0.92%-14.6M |
| Impairment and provisions: | --0 | 1,011.60%288.84M | --0 | --25.98M | --0 | --0 | --0 | --0 | --0 | --0 |
| -Impairment of goodwill | ---- | --75.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 719.52%212.94M | ---- | --25.98M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | --0 | 6,736.52%336.87M | --0 | 98.67%-5.08M | --0 | -333.28%-382.36M | --0 | ---88.25M | --0 | --0 |
| -Derivative financial instruments fair value (increase) | ---- | 5,969.97%859.57M | ---- | 103.70%14.16M | ---- | -333.28%-382.36M | ---- | ---88.25M | ---- | ---- |
| -Other fair value changes | ---- | -2,617.15%-522.7M | ---- | ---19.24M | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | --0 | -95.70%820K | --0 | 261.97%19.07M | --0 | 9.20%5.27M | --0 | 117.93%4.83M | --0 | 541.74%2.21M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -95.70%820K | ---- | 261.97%19.07M | ---- | 9.20%5.27M | ---- | 117.93%4.83M | ---- | 541.74%2.21M |
| Depreciation and amortization: | --0 | 45.24%377.36M | --0 | 111.70%259.82M | --0 | 42.40%122.73M | --0 | 41.08%86.19M | --0 | 39.49%61.09M |
| -Depreciation | ---- | 48.22%148.95M | ---- | 54.50%100.5M | ---- | 29.49%65.05M | ---- | 47.28%50.23M | ---- | 32.16%34.11M |
| -Other depreciation and amortization | ---- | 43.36%228.4M | ---- | 176.21%159.32M | ---- | 60.44%57.68M | ---- | 33.25%35.95M | ---- | 50.00%26.98M |
| Financial expense | ---- | 15.52%281.65M | ---- | -0.16%243.81M | ---- | 19.41%244.21M | ---- | 14,321.93%204.5M | ---- | -66.94%1.42M |
| Exchange Loss (gain) | ---- | 588.39%241.73M | ---- | 67.08%-49.5M | ---- | -270.35%-150.36M | ---- | 930.88%88.26M | ---- | -145.02%-10.62M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -79.60%6.84M | ---- | --33.54M |
| Operating profit before the change of operating capital | --0 | 945.86%1.56B | --0 | -122.36%-184.42M | --0 | -67.46%824.93M | --0 | 115.71%2.54B | --0 | 45.92%1.18B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -135.84%-35.33M | ---- | 153.01%98.57M | ---- | -563.27%-185.95M | ---- | 63.27%-28.04M | ---- | -436.85%-76.32M |
| Accounts receivable (increase)decrease | ---- | -145.54%-530.59M | ---- | -114.96%-216.1M | ---- | 188.77%1.44B | ---- | -470.68%-1.63B | ---- | 30.04%-285.06M |
| Accounts payable increase (decrease) | ---- | 353.52%961.31M | ---- | 20.97%-379.18M | ---- | -138.23%-479.79M | ---- | 1,015.42%1.25B | ---- | -66.85%112.51M |
| Cash from business operations | 230.34%1.35B | 387.07%1.96B | 189.02%407.69M | -142.48%-681.13M | -128.02%-457.97M | -24.93%1.6B | 29.83%1.63B | 130.50%2.14B | 68.66%1.26B | 21.89%926.49M |
| China income tax paid | 60.06%-101.96M | -1,471.94%-255.43M | -6,570.13%-255.27M | 106.13%18.62M | 98.70%-3.83M | 10.97%-303.73M | -46.69%-295.48M | -61.61%-341.15M | -75.87%-201.44M | -136.22%-211.1M |
| Net cash from operations | 716.65%1.24B | 356.59%1.7B | 133.01%152.43M | -150.98%-662.51M | -134.49%-461.8M | -27.58%1.3B | 26.62%1.34B | 150.83%1.79B | 67.36%1.06B | 6.66%715.39M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 878.64%31.06M | -40.60%6.74M | -60.89%3.17M | -54.59%11.35M | -41.90%8.12M | -30.66%24.99M | 100.62%13.97M | 146.82%36.04M | 46.82%6.96M | -0.92%14.6M |
| Restricted cash (increase) decrease | -2,057.98%-1.17B | -88.23%15.21M | -162.26%-54.15M | 158.41%129.2M | --86.98M | ---221.19M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | -129.09%-100M | 395.81%352.99M |
| Sale of fixed assets | ---- | 2,790.91%954K | 4,857.89%942K | -99.83%33K | -99.90%19K | 332.42%19.62M | --19.76M | --4.54M | ---- | ---- |
| Purchase of fixed assets | 25.57%-215.59M | -60.00%-570.07M | -10.86%-289.65M | 64.16%-356.29M | 32.28%-261.26M | -72.51%-994.16M | -50.28%-385.78M | 7.06%-576.28M | 22.70%-256.7M | -89.59%-620.04M |
| Purchase of intangible assets | 99.70%-301K | -79.77%-207.88M | -6.20%-100.17M | 85.06%-115.64M | ---94.32M | 18.96%-774.2M | ---- | -100.66%-955.32M | ---- | -989.21%-476.08M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---78.16M | ---- | ---- |
| Recovery of cash from investments | --2.61B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --45M | ---- |
| Cash on investment | ---15.2M | ---290M | ---- | ---- | ---- | ---- | 49.66%-612.95M | ---- | -1,049.47%-1.22B | ---- |
| Other items in the investment business | 44.59%-20.55M | 30.29%-75.12M | 46.23%-37.08M | 28.01%-107.76M | ---68.96M | -5.93%-149.68M | ---- | ---141.31M | ---- | ---- |
| Net cash from investment operations | 355.34%1.22B | -155.10%-1.12B | -44.77%-476.93M | 79.04%-439.11M | 65.86%-329.43M | -22.46%-2.09B | 36.61%-965M | -134.79%-1.71B | -1,600.36%-1.52B | -18.97%-728.53M |
| Net cash before financing | 858.89%2.46B | 152.63%579.75M | 58.99%-324.5M | -38.54%-1.1B | -311.56%-791.23M | -1,047.45%-795.14M | 180.46%373.99M | 738.79%83.92M | -185.70%-464.81M | -122.50%-13.14M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 545.60%1.68B | 16.40%517.94M | -5.66%260.77M | -14.10%444.96M | -33.31%276.4M | -27.37%518.01M | 36.85%414.43M | 1,543.36%713.2M | --302.84M | --43.4M |
| Refund | 80.71%-22.2M | -2.92%-162.28M | 25.08%-115.08M | -12,514.24%-157.68M | ---153.6M | 99.57%-1.25M | ---- | -2,800.00%-290M | ---- | 85.71%-10M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.7B | --2.7B | ---- |
| Interest paid - financing | 15.71%-78.41M | -51.61%-151.3M | ---93.02M | ---99.8M | ---- | ---- | -39,286.64%-85.47M | ---- | 58.51%-217K | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 69.45%-219.99M | ---- | -127.56%-720.03M | -101.17%-150.15M | 0.00%-316.42M |
| Issuance expenses and redemption of securities expenses | ---1.1B | ---971.39M | ---- | ---- | ---- | 48.84%-136.92M | -7.66%-136.92M | ---267.62M | ---127.18M | ---- |
| Other items of the financing business | ---82.5M | ---20M | ---- | ---- | ---49.19M | -151.59%-95.22M | ---- | -2,539.19%-37.85M | ---- | ---1.43M |
| Net cash from financing operations | 650.94%395.49M | -519.79%-787.03M | -28.45%52.67M | 190.07%187.48M | -61.67%73.61M | -96.92%64.63M | -92.96%192.05M | 838.27%2.1B | 3,729.18%2.73B | 23.42%-284.45M |
| Effect of rate | 87.23%-24K | -202.75%-299K | -163.95%-188K | 107.93%291K | -70.60%294K | -353.21%-3.67M | 11.73%1M | -65.10%1.45M | -41.31%895K | 135.18%4.15M |
| Net Cash | 1,151.40%2.86B | 77.33%-207.28M | 62.12%-271.84M | -25.14%-914.14M | -226.78%-717.62M | -133.45%-730.5M | -74.98%566.04M | 833.88%2.18B | 384.34%2.26B | 4.95%-297.59M |
| Begining period cash | -18.35%923.54M | -44.69%1.13B | -44.69%1.13B | -26.42%2.04B | -26.42%2.04B | 368.07%2.78B | 368.07%2.78B | -33.08%593.75M | -33.08%593.75M | -26.80%887.18M |
| Cash at the end | 340.18%3.78B | -18.35%923.54M | -35.29%859.1M | -44.69%1.13B | -60.32%1.33B | -26.42%2.04B | 17.10%3.35B | 368.07%2.78B | 110.74%2.86B | -33.08%593.75M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) Guangzhou Branch |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg